Intarcia Therapeutics' Series C Round

Intarcia Therapeutics raised a round of funding on November 15, 2012.

Intarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging disea…

Articles about Intarcia Therapeutics' Series C Round: